Acquisition broadens oncology pipeline with a portfolio of novel T-cell engagers including HPN328 (MK-6070), an investigational delta-like ligand 3 (DLL3) targeting T-cell engager
India is contributing 13% to the global asthma burden and a disproportionate 43% of the global asthma deaths.
AbCellera will receive an upfront payment and is eligible to receive additional milestone payments
Zydus Lifesciences receives EIR report from USFDA for API Ahmedabad facility
Women emerge as the cornerstone of this monumental undertaking
The product combines proven efficacy of Doxylamine succinate 20 mg and Pyridoxine hydrochloride 20 mg in an Extended Release formulation
The plan is to set up an ultramodern Solvent Recovery Plant for third party purposes
ANVISA issues CGMP to Concord Biotech’s Unit I
Nectar Lifesciences has clarified that the company has no relation/connection/ association or link of any nature with the Nectar Herbs and Drugs
The facility will manufacture Specialty and Fine Chemicals tailored to various applications across industries such as Polymer and Water Treatment facilities
Group sales came in at 47.637 billion euros, down 1.2% on a currency- and portfolio-adjusted basis
Acquisition of exclusive commercialization rights for European markets
The Convocation ceremony was organized for students skilled and certified in Ayush
This agreement paves the way for the introduction of YESAFILI into the Canadian market
Launch of Indian public health standards for Ayush healthcare facilities
ICMR’s budgetary allowance has increased by 4-fold in the past 10 years, showcasing our commitment towards Health Research
With this, the total number of Patents granted to company for its innovative processes and technology stands at 9
EDQM conducts GMP inspection of SMS Pharmaceuticals’ API facility
The production started from its greenfield manufacturing facility at Aurangabad in Maharashtra
Cipla completes transfer of Generics Business Undertaking
Subscribe To Our Newsletter & Stay Updated
